In subsequent Phase 2 trials, once-weekly subcutaneous injections of retatrutide at doses of 4 mg, 8 mg, and 12 mg resulted in marked improvements in glycemic control compared to placebo, along with substantial weight loss when contrasted with placebo and dulaglutide (1.5 mg)
"We're not having any bad side effects, so why go off of it?" she said, adding "it's helped both of us get to the weight we want."
If UBT-251 global reads out above 20%, Novo has a credible fast-follower to Retatrutide
Video Walkthrough To see the reconstitution and the unit math demonstrated alongside the chart, this retatrutide-specific walkthrough covers the full mixing process
European Society of Human Reproduction and Embryology
Inquire about licensing here